Contribute Try STAT+ Today

Good morning, everyone, and welcome to another working week. Once again, another delightful weekend respite has come and gone, leaving us with the familiar challenge of tackling virtual meetings, deadlines, and a growing to-do list. No doubt, you can relate, yes? So please join us as we enjoy another cup of stimulation — as you know, a prescription is not required — and dig in for another busy day. Meanwhile, here are a few items of interest. Hope you have a smashing day and do stay in touch. …

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.